nCoV Map

Omicron cases doubling in European Region
24 January, 2022
Statement from WHO Regional Director for Europe…
COVID-19
Novavax approved for emergency use
Belgium // 24 January, 2022
First doses to arrive in February…
COVID-19
WHO Director General opens the 150th session of the Executive Board
24 January, 2022
150th session of WHO Executive Board opening remarks...
COVID-19
Study: Increased antibodies with differing booster vaccines after Sinovac primary schedule
24 January, 2022
Booster with different vaccine after Sinovac/CoronaVac is more effective...
COVID-19
Study: COVID-19 may infect the inner ear causing symptoms
24 January, 2022
COVID-19 may infect the inner ear leading to pain, hearing loss, tinnitus...
COVID-19
Vaccination for children and fourth booster shots planned
Thailand // 24 January, 2022
Vaccintion for children between 5 and 11 years; fourth vaccine dose for residents in...
COVID-19
Omicron sub-lineage BA.2 as variant under investigation (VUI)
United Kingdom // 22 January, 2022
UK Health Security Agency (UKHSA) has stated...
COVID-19
Strong antibody response among those infected with COVID-19 post-vaccination, study
United States // 22 January, 2022
The more exposure to SARS-CoV-2 antigens, the more enhanced the quality of antibody responses...
COVID-19
CDC studies show booster doses protective against Omicron
United States // 21 January, 2022
Two studies from the CDC show that booster doses were protective against...
COVID-19
WHO SAGE meeting from 19 January
21 January, 2022
Booster doses recommended…
COVID-19
PAHO statement regarding Omicron wave in the Americas
21 January, 2022
Omicron variant driving hospitalisation and illness…
COVID-19
Age for Paxlovid administration lowered; new testing guidelines announced
South Korea // 21 January, 2022
Health authorities have lowered (in Korean) the age for Paxlovid administration from 65 to...
COVID-19
Risks for COVID-19 infection and hospitalization following previous infection and vaccination
21 January, 2022
Vaccination is protective
COVID-19
ECDC analysis of COVID-19 vaccine effectiveness
20 January, 2022
The ECDC released an interim analysis on a multi-country vaccine effectiveness study that is ongoing...
COVID-19
CDC study on COVID-19 cases and hospitalizations by COVID-19 vaccination status and previous COVID-19 diagnosis
United States // 20 January, 2022
Evidence shows that both COVID-19 vaccination and prior infection protected individuals against infection and hospitalization...
COVID-19
Study: Females may have a higher risk of COVID-19 related symptoms post recovery
20 January, 2022
Females infected with COVID-19 may have a higher risk of developing...
COVID-19
Government revises approach to testing and isolation requirements
Australia // 20 January, 2022
Rapid antigen testing for current high community prevalence environment...
COVID-19
COVID-19 Update – Tokyo and 15 other prefectures under semi state of emergency
Japan // 20 January, 2022
Authorities have announced that Tokyo Metropolitan area and another 12 prefectures will be placed under semi-state of emergency...
COVID-19
Omicron cases detected
Bulgaria // 20 January, 2022

COVID-19
Oral medications Paxlovid and Molnupiravir approved for treatment of COVID-19
Australia // 19 January, 2022
Both prescription medications are for adults at high risk of severe illness....
COVID-19

Quick Links

nCoV Map

LATEST NEWS (PREMIUM ACCESS)